Oroxylin A has therapeutic potential in acute myelogenous leukemia by dual effects targeting PPARγ and RXRα-Reference-Cited by-同舟云学术

Oroxylin A has therapeutic potential in acute myelogenous leukemia by dual effects targeting PPARγ and RXRα

Published:2013-09-03 Issue:5 Volume:134 Page:1195-1206
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Hui Hui¹,Chen Yan¹,Yang Hao¹,Zhao Kai¹,Wang Qian¹,Zhao Li¹,Wang Xiaotang²,Li Zhiyu¹,Lu Na¹,Guo Qinglong¹

Affiliation:

1. State Key Laboratory of Natural MedicinesJiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical UniversityNanjing People's Republic of China

2. Department of Chemistry and BiochemistryFlorida International UniversityMiami FL

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.28435

Reference52 articles.

1. Differentiation therapy of leukemia: 3 decades of development

2. Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy

3. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia [see comments]

4. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages

5. PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and molecular mechanisms of oroxylin A in cancer therapy: Recent advances;European Journal of Pharmacology;2024-04

2. Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-10-10

3. Chemical Constituents With Antiproliferative Activity From Pogostemon cablin (Blanco) Benth.;Frontiers in Chemistry;2022-07-15

4. Targeting cyclin-dependent kinase 9 in cancer therapy;Acta Pharmacologica Sinica;2021-11-22

5. Oroxylin A inhibits the migration of hepatocellular carcinoma cells by inducing NAG-1 expression;Acta Pharmacologica Sinica;2021-06-11